Literature DB >> 18836724

[Tissue bank of the National Centre for Tumour Disease. An innovative platform for translational tumour].

E Herpel1, N Koleganova, P Schirmacher.   

Abstract

The tissue bank of the National Centre for Tumour Diseases (NCT) in Heidelberg, Germany, was founded in 2005 by the University Hospital of Heidelberg and the German Cancer Research Centre as a section of the NCT. It is a nonprofit organization with a completely evaluated legal and ethical framework and supports the Comprehensive Cancer Centre concept. Its main aim is the acquisition and characterization of fresh-frozen and paraffin-embedded human tissues according to the standards of good scientific practice and the promotion of interdisciplinary tumour research of the comprehensive cancer centre and its cooperating partners. It also offers expert project assistance: a project leader can submit a short proposal, and the tissue collecting/preparing process will be performed in cooperation with a specialised pathologist and, if applicable, an experienced clinical researcher. The tissue bank is also a central platform for further developing of innovative technologies for tissue handling, e.g. multi-tissue-array and virtual microscopy, with links to digital image analysis and bioinformatics. Thus, the NCT tissue bank represents a model for innovative biobanking and for institutions with active interdisciplinary cancer research.

Entities:  

Mesh:

Year:  2008        PMID: 18836724     DOI: 10.1007/s00292-008-1067-2

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  7 in total

1.  Structural requirements of research tissue banks derived from standardized project surveillance.

Authors:  E Herpel; N Koleganova; B Schreiber; B Walter; C V Kalle; P Schirmacher
Journal:  Virchows Arch       Date:  2012-06-01       Impact factor: 4.064

2.  Quality management and accreditation of research tissue banks: experience of the National Center for Tumor Diseases (NCT) Heidelberg.

Authors:  Esther Herpel; Christoph Röcken; Heike Manke; Peter Schirmacher; Christa Flechtenmacher
Journal:  Virchows Arch       Date:  2010-10-27       Impact factor: 4.064

Review 3.  [Merging different biobanks under one roof : Benefits and constraints on the way to a centralized biobank using the example of the BMBH].

Authors:  S Schmitt; C Döllinger; A Maier; E Herpel; P Schirmacher; R Kirsten
Journal:  Pathologe       Date:  2018-07       Impact factor: 1.011

Review 4.  [Preanalytics and biobanking : Influence of preanalytical factors on tissue sample quality].

Authors:  K-F Becker; J Wipperfürth; E Herpel
Journal:  Pathologe       Date:  2018-07       Impact factor: 1.011

5.  Tissue banking in a regional hospital: a promising future concept? First report on fresh frozen tissue banking in a hospital without an integrated institute of pathology.

Authors:  Marco von Strauss und Torney; Ulrich Güller; Farid Rezaeian; Philippe Brosi; Luigi Terracciano; Markus Zuber
Journal:  World J Surg       Date:  2012-10       Impact factor: 3.352

Review 6.  From tissue to molecular phenotyping: pre-analytical requirements heidelberg experience.

Authors:  Thomas R Muley; Felix Jf Herth; Philipp A Schnabel; Hendrik Dienemann; Michael Meister
Journal:  Transl Lung Cancer Res       Date:  2012-06

Review 7.  MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons.

Authors:  Tarek Shalaby; Giulio Fiaschetti; Martin Baumgartner; Michael A Grotzer
Journal:  Int J Mol Sci       Date:  2014-11-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.